2000
DOI: 10.1016/s1590-8658(00)80260-1
|View full text |Cite
|
Sign up to set email alerts
|

Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0
1

Year Published

2002
2002
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(27 citation statements)
references
References 26 publications
1
25
0
1
Order By: Relevance
“…In these instances, however, 16 publications (42.1 %) gave preference to the SF-36 while only one article (2.6 %) (indirectly) rated the NHP higher. In this study Bianchi et al (2000) report that the NHP registered group differences in health-related quality of life between hepatological patients who received interferon treatment and those who did not; however, the differences were not significant when the SF-36 was used [10]. This one instance of a preference for the NHP is in contrast to a large body of publications that drew the opposite conclusion.…”
Section: Nhp and Sf-36mentioning
confidence: 71%
“…In these instances, however, 16 publications (42.1 %) gave preference to the SF-36 while only one article (2.6 %) (indirectly) rated the NHP higher. In this study Bianchi et al (2000) report that the NHP registered group differences in health-related quality of life between hepatological patients who received interferon treatment and those who did not; however, the differences were not significant when the SF-36 was used [10]. This one instance of a preference for the NHP is in contrast to a large body of publications that drew the opposite conclusion.…”
Section: Nhp and Sf-36mentioning
confidence: 71%
“…So, treatment for HCV is lengthy, rigorous, and associated with side effects that are difficult to manage [7].…”
Section: Introductionmentioning
confidence: 99%
“…(15)(16). To date, the causal factors of a reduced HRQoL in such patients are poorly understood, even though psychological and social impact of Hepatitis C Virus (HCV) infection diagnosis, as well as HCV itself and interferon treatment, seem to play a crucial role (17)(18)(19). On the other hand, neither the stage of the liver disease nor the viral load nor the presence of extrahepatic manifestations seem to influence the HRQoL (20).…”
mentioning
confidence: 99%